share_log

B of A Securities Upgrades Novavax to Neutral, Raises Price Target to $12

B of A Securities Upgrades Novavax to Neutral, Raises Price Target to $12

Bof A證券將Novavax上調至中性,將目標股價上調至12美元
Benzinga ·  05/10 13:33

B of A Securities analyst Alec Stranahan upgrades Novavax (NASDAQ:NVAX) from Underperform to Neutral and raises the price target from $4 to $12.

B of A Securities分析師亞歷克·斯特拉納漢將Novavax(納斯達克股票代碼:NVAX)從表現不佳上調至中性,並將目標股價從4美元上調至12美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論